THE CHROMOSOME | Clinical Content Series
Parathyroid Disorders
Back to Case Studies ArchiveCase Study
He was 49 years old and had been referred to me by a nephrologist, which is an unusual referral pathway for an obesity clinic, but one that made complete clinical sense once I understood his history. He had developed kidney stones twice in three years. His nephrologist had investigated and found persistently elevated calcium in both his blood and urine. He had been told his kidneys needed monitoring and his fluid intake needed increasing. The calcium elevation had been noted. Its cause had not been pursued.
He had also gained 21 kilograms across four years. He was profoundly fatigued, not the fatigue of poor sleep or excessive work but a deeper, more physical exhaustion that he described as his muscles simply not working properly. He had developed bone pain across his lower back and hips that his general physician had attributed to his weight and his sedentary occupation. He was constipated chronically. His mood was flat and his concentration had deteriorated in ways he found difficult to articulate, a cognitive blunting that had arrived so gradually he had not registered it as a symptom until his work performance began to reflect it.
Bones. Stones. Groans. Moans. This is the classical tetrad of primary hyperparathyroidism, the four symptomatic domains through which excess parathyroid hormone announces itself in the body, and it was sitting in front of me in a Pakistani man who had been seeing multiple physicians across four years without a single one of them measuring his parathyroid hormone level.
His intact parathyroid hormone was more than three times the upper limit of normal. His serum calcium was consistently elevated. His vitamin D was severely deficient, which was both a consequence of the parathyroid disorder and a driver of its severity, because vitamin D deficiency is one of the most potent stimulants of parathyroid hormone secretion. His bone density scan showed significant osteoporosis across the lumbar spine and femoral neck, a degree of bone loss that should not have been present in a forty nine year old Pakistani man without an identified cause, and that had been entirely attributed to his sedentary lifestyle without any hormonal investigation.
Primary hyperparathyroidism, the autonomous overproduction of parathyroid hormone by one or more parathyroid glands, is one of the most commonly missed endocrine diagnoses in Pakistani medicine, not because it is rare but because parathyroid hormone is almost never measured as part of a standard metabolic panel. Pakistani patients with the classical presentation, kidney stones, elevated calcium, bone pain, fatigue, constipation, and cognitive blunting, are managed for each symptom individually by separate specialists who never communicate with each other and never order the single blood test that connects every symptom to its hormonal origin.
The relationship between parathyroid disorders and obesity in Pakistani patients is bidirectional and clinically important. Primary hyperparathyroidism drives weight gain and metabolic deterioration through multiple simultaneous mechanisms, and obesity, through the vitamin D deficiency it promotes and the inflammatory environment it generates, drives secondary hyperparathyroidism that creates its own distinct pattern of hormonal and metabolic disruption. Understanding which direction the relationship is operating in each individual patient requires the kind of comprehensive hormonal and metabolic assessment that THE CHROMOSOME protocol provides and that standard Pakistani endocrine medicine almost never performs.
The FTO gene's influence on parathyroid health in Pakistani patients operates primarily through its promotion of visceral fat accumulation and the consequent vitamin D deficiency that visceral obesity drives. Vitamin D is sequestered in adipose tissue, particularly visceral adipose tissue, reducing its bioavailability in the bloodstream and creating a state of functional vitamin D deficiency that stimulates parathyroid hormone secretion compensatorily. In Pakistani patients with significant visceral obesity and the FTO associated predisposition to fat accumulation, this vitamin D sequestration produces a chronic parathyroid stimulation that creates the secondary hyperparathyroidism pattern, elevated parathyroid hormone in the presence of low to normal calcium, that is present in a substantial proportion of the Pakistani obesity patients I evaluate and that is almost never identified because parathyroid hormone is almost never measured.
His case required surgical management, a single parathyroid adenoma was identified on imaging and removed by a parathyroid surgeon. But the surgical treatment of his parathyroid adenoma was only the beginning of his management. We simultaneously addressed the profound vitamin D deficiency that had been amplifying his parathyroid hormone secretion and accelerating his bone loss. We treated his insulin resistance, which had been contributing to his metabolic deterioration and which became more apparent once the masking effects of hypercalcaemia were removed. We recalibrated his cortisol pattern. We implemented an aggressive bone density recovery protocol, because the osteoporosis he had developed required active treatment, not simply the removal of the parathyroid stimulus.
Fourteen months after his parathyroid surgery and within the comprehensive metabolic programme, he had lost 17 kilograms. His calcium had normalised. His kidney stone risk had substantially reduced. His bone density had improved measurably, reflecting the bone recovery that becomes possible when the parathyroid hormone driven bone resorption is removed and the anabolic conditions for bone formation are actively supported. His fatigue had resolved. His cognitive function had returned. His mood had lifted in a way he had not anticipated, because he had not recognised the cognitive and mood consequences of chronic hypercalcaemia until their resolution revealed how significantly they had been affecting his quality of life.
He told me at his review that he felt as though someone had removed a weight from every cell in his body simultaneously. That is precisely what removing a parathyroid adenoma from a patient who has been living with its consequences for years actually feels like, because calcium governs cellular function at the most fundamental biological level, and correcting its excess restores that function across every tissue simultaneously.
FAQs
The parathyroid glands are four small glands located behind the thyroid that produce parathyroid hormone, the primary regulator of calcium and phosphate balance in the body. Parathyroid hormone raises blood calcium by stimulating bone to release calcium into the bloodstream, directing the kidneys to retain calcium rather than excrete it, and activating vitamin D to increase calcium absorption from the gut. When one or more parathyroid glands develops an adenoma, a benign tumour that produces parathyroid hormone autonomously, calcium rises persistently above normal levels, producing a constellation of symptoms across bones, kidneys, digestive system, nervous system, and metabolism that Pakistani medicine almost universally manages symptom by symptom without identifying the parathyroid origin driving all of them simultaneously.
Excess parathyroid hormone and the resulting hypercalcaemia drive weight gain and metabolic deterioration through multiple simultaneous mechanisms. Elevated calcium impairs insulin signalling at the cellular level, reducing glucose uptake in muscle and adipose tissue and driving insulin resistance independently of the dietary and genetic factors that typically produce it in Pakistani patients. Chronic hypercalcaemia produces the profound fatigue and muscle weakness that reduces physical activity and caloric expenditure substantially. Excess parathyroid hormone drives bone calcium mobilisation continuously, producing a catabolic hormonal environment that simultaneously impairs muscle function and reduces the anabolic capacity required for metabolic health maintenance. And the psychological consequences of chronic hypercalcaemia, the cognitive blunting, the motivational flatness, the depression, reduce the behavioural engagement with dietary and physical activity that might otherwise partially compensate for the metabolic deterioration.
The FTO gene at Chromosome 16q12.2 drives parathyroid dysfunction in Pakistani patients primarily through its promotion of visceral fat accumulation and the consequent vitamin D sequestration that visceral adiposity produces. Vitamin D is fat soluble and is sequestered within adipose tissue, particularly the visceral adipose tissue that the FTO associated metabolic profile promotes at lower body weight thresholds in Pakistani patients than in Western populations. This sequestration reduces circulating vitamin D bioavailability, creating a state of functional vitamin D deficiency that drives compensatory parathyroid hormone secretion. In Pakistani patients with significant visceral obesity, this vitamin D sequestration driven secondary hyperparathyroidism produces an elevated parathyroid hormone with low to normal calcium that creates its own pattern of bone, kidney, and metabolic consequences, distinct from primary hyperparathyroidism but equally important and equally undertreated.
Vitamin D is the primary inhibitory regulator of parathyroid hormone secretion, adequate vitamin D suppresses parathyroid hormone production through direct feedback on parathyroid gland function. When vitamin D is deficient, this inhibitory feedback is removed and parathyroid hormone rises compensatorily, producing secondary hyperparathyroidism that drives bone resorption, impairs renal calcium handling, and creates the metabolic consequences of parathyroid excess even without a parathyroid adenoma. Pakistan has extraordinarily high rates of vitamin D deficiency despite abundant sunlight, driven by cultural practices of sun avoidance, dietary inadequacy, and the adipose sequestration of visceral obesity. Dr. Zaar finds profound vitamin D deficiency in virtually every Pakistani obesity patient evaluated comprehensively, and treats it as a parathyroid health intervention, a bone protection measure, an immune regulator, and a metabolic support simultaneously.
Primary hyperparathyroidism is caused by an autonomous parathyroid gland, typically a benign adenoma, producing parathyroid hormone independently of the normal regulatory feedback, resulting in elevated calcium alongside elevated parathyroid hormone. Secondary hyperparathyroidism is a compensatory response to low calcium or vitamin D deficiency, the parathyroid glands produce excess hormone appropriately in response to a biological signal demanding more calcium mobilisation, resulting in elevated parathyroid hormone with low to normal calcium. In Pakistani obesity patients, secondary hyperparathyroidism driven by profound vitamin D deficiency and calcium inadequacy is substantially more prevalent than primary hyperparathyroidism, yet it is almost never identified because parathyroid hormone is not routinely measured. The distinction matters because treatment is fundamentally different, primary requires surgical management in appropriate cases, while secondary resolves with vitamin D and calcium restoration.
Excess parathyroid hormone drives continuous bone resorption, mobilising calcium from bone tissue into the bloodstream at a rate that exceeds the body's capacity for bone formation, producing progressive bone density loss that accumulates across the years of undiagnosed parathyroid excess. In Pakistani patients whose bone health is already compromised by vitamin D deficiency, low testosterone or oestrogen, cortisol excess, and the inflammatory burden of visceral obesity, hyperparathyroidism adds a substantial additional osteolytic insult that accelerates bone loss and fracture risk beyond what any individual hormonal disorder would produce alone. Pakistani men and women with undiagnosed primary hyperparathyroidism frequently present with osteoporosis at ages where it should not yet be clinically significant, and the parathyroid origin of their bone loss is identified only when someone thinks to measure parathyroid hormone alongside the calcium that should have prompted its measurement years earlier.
Excess parathyroid hormone increases urinary calcium excretion, the kidneys filter the elevated serum calcium and excrete the excess into the urine, creating a hypercalciuric state in which calcium concentration in the urinary tract exceeds the solubility threshold and precipitates as calcium oxalate or calcium phosphate stones. Pakistani patients with primary hyperparathyroidism develop recurrent kidney stones, often the presenting event that brings them to medical attention, yet the investigation of kidney stones in Pakistani nephrology and urology practice almost never includes parathyroid hormone measurement as a standard step. The calcium elevation that hyperparathyroidism produces is identified on the routine chemistry that accompanies stone investigation, but its parathyroid origin is pursued in only a minority of cases, leaving the majority of Pakistani patients with hyperparathyroidism related kidney stones managed for recurrent stones without addressing the hormonal condition producing them.
THE CHROMOSOME protocol includes parathyroid hormone measurement as a standard component of comprehensive hormonal assessment in Pakistani obesity patients, because the prevalence of both primary and secondary parathyroid dysfunction in this population is substantially higher than Pakistani clinical practice recognises, and because both conditions contribute meaningfully to the metabolic and hormonal deterioration that drives obesity and its complications. Where primary hyperparathyroidism requiring surgical management is identified, Dr. Zaar coordinates the surgical pathway while simultaneously optimising the metabolic and hormonal environment for post surgical recovery. Where secondary hyperparathyroidism driven by vitamin D deficiency and visceral obesity is identified, comprehensive treatment addresses vitamin D restoration, calcium adequacy, visceral fat reduction, and the full hormonal picture simultaneously, because parathyroid health in Pakistani obesity patients is never an isolated finding and never responds to an isolated intervention.